Literature DB >> 12064512

Reduction of neuronal and inducible nitric oxide synthase gene expression in patients with cystic fibrosis.

Jörg Dötsch1, Jan Puls, Thorsten Klimek, Wolfgang Rascher.   

Abstract

As a consequence of diminished nitric oxide synthase (NOS) protein concentration, the airway concentration of nitric oxide (NO) is reduced in patients with cystic fibrosis (CF). This appears to lead to a reduced elimination of such microorganisms as Pseudomonas aeruginosa. The objective of this study was to analyze whether inducible (iNOS), endothelial (eNOS) and neuronal (bNOS) NOS are reduced at mRNA level and if so whether this is caused directly by the defective CF transmembrane conductance regulator (CFTR). Nasal polyps from three patients with CF and four otherwise healthy patients were obtained. The expression of the three NOS isoenzymes was quantified using real-time PCR. The iNOS expression was assessed in colon carcinoma cells (CaCo) transfected with a normal and a mutated (DeltaF508) CFTR. In CF patients, iNOS mRNA expression was 10-to 20-fold and bNOS gene expression was one-fifth to one-tenth that in control patients (P < 0.001). In CaCo cells, iNOS gene expression under basal and endotoxin-stimulated conditions did not differ between cells transfected with a mutated CFTR and those transfected with an intact CFTR. This observation suggests that cystic fibrosis is associated with reduced iNOS and bNOS gene expression in nasopharyngeal tissue, possibly disturbing the barrier against infective agents already at the site of entrance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12064512     DOI: 10.1007/s00405-001-0436-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  10 in total

1.  The effect of corticosteroid therapy on cyclooxygenase 2, vascular endothelial growth factor, and inducible nitric oxide synthase expression levels in nasal polyposis.

Authors:  Demet Yazici; Ülkü Tuncer; Aysun Uğuz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06       Impact factor: 2.503

2.  Endothelial nitric oxide synthase/soluble guanylate cyclase system in human nasal polyps.

Authors:  Paloma Escobar; Francisco J Márquez; Carolina Carrasco; Sergio Alonso-Orgaz; José Fortes; Carlos Cenjor; Antonio López-Farré
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-11-18       Impact factor: 2.503

3.  Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath.

Authors:  C Lane; D Knight; S Burgess; P Franklin; F Horak; J Legg; A Moeller; S Stick
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

4.  Nitric oxide synthase 1 as a potential modifier gene of decline in lung function in patients with cystic fibrosis.

Authors:  J Texereau; S Marullo; D Hubert; J Coste; D J Dusser; J Dall'Ava-Santucci; A T Dinh-Xuan
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

5.  cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells.

Authors:  Mary E Manson; Deborah A Corey; Nicole M White; Thomas J Kelley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-12       Impact factor: 5.464

6.  Increased oxidative stress induces apoptosis in human cystic fibrosis cells.

Authors:  Mathilde Rottner; Simon Tual-Chalot; H Ahmed Mostefai; Ramaroson Andriantsitohaina; Jean-Marie Freyssinet; María Carmen Martínez
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

7.  The anti-sigma factor MucA of Pseudomonas aeruginosa: Dramatic differences of a mucA22 vs. a ΔmucA mutant in anaerobic acidified nitrite sensitivity of planktonic and biofilm bacteria in vitro and during chronic murine lung infection.

Authors:  Warunya Panmanee; Shengchang Su; Michael J Schurr; Gee W Lau; Xiaoting Zhu; Zhaowei Ren; Cameron T McDaniel; Long J Lu; Dennis E Ohman; Daniel A Muruve; Ralph J Panos; Hongwei D Yu; Thomas B Thompson; Boo Shan Tseng; Daniel J Hassett
Journal:  PLoS One       Date:  2019-06-03       Impact factor: 3.240

Review 8.  Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine.

Authors:  Afsoon Sepahzad; Deborah J Morris-Rosendahl; Jane C Davies
Journal:  Genes (Basel)       Date:  2021-04-13       Impact factor: 4.096

Review 9.  Mechanisms of the noxious inflammatory cycle in cystic fibrosis.

Authors:  Mathilde Rottner; Jean-Marie Freyssinet; M Carmen Martínez
Journal:  Respir Res       Date:  2009-03-13

Review 10.  Genetic Modifying Factors of Cystic Fibrosis Phenotype: A Challenge for Modern Medicine.

Authors:  Lăcrămioara Ionela Butnariu; Elena Țarcă; Elena Cojocaru; Cristina Rusu; Ștefana Maria Moisă; Maria-Magdalena Leon Constantin; Eusebiu Vlad Gorduza; Laura Mihaela Trandafir
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.